Supplementary Material for: Abnormal Baseline Lab Results Rarely Lead to Treatment Modification for Patients on Isotretinoin Article Swipe

View

Elizabeth Tkachenko , Preety Sharma , Arash Mostaghimi ·

YOU? · · 2020 · Open Access · · DOI: https://doi.org/10.6084/m9.figshare.11865603

Background: Treatment modification and clinical course for patients initiating isotretinoin with abnormal baseline lab results is currently unknown, and no recommendations exist for monitoring this patient group. Methods: We performed a retrospective review of patients prescribed isotretinoin for acne from 2008 to 2016 at Brigham and Women’s and Massachusetts General Hospitals to investigate the characteristics, clinical implications, and management of patients initiating isotretinoin for acne with baseline laboratory abnormalities. Results: We identified a low rate (7.2%) of treatment modification, including interruption (3.6%) and early termination (3.6%), during isotretinoin therapy due to lab abnormalities for patients with baseline lab abnormalities. Abnormal baseline total cholesterol, triglyceride, and liver function tests did not predict management changes, as only 2 of 10 total treatment modifications were due to a lab result that was abnormal at baseline. Treatment modification was driven by ALT elevation not present at baseline that occurred in patients with liver comorbidities. Conclusion: Emphasizing relevant comorbidities, including hepatic disease or alcohol use, to inform our monitoring may be a superior predictor of abnormalities during treatment, as our work demonstrates that the value of baseline lab data prior to isotretinoin is unclear.

Related Topics

Concepts

Isotretinoin Lead (geology) Baseline (sea) Medicine Internal medicine Dermatology Biology Acne Fishery Paleontology

Metadata

Type: dataset
Language: en
Landing Page: https://doi.org/10.6084/m9.figshare.11865603
OA Status: gold
Related Works: 10
OpenAlex ID: https://openalex.org/W4394545614

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4394545614

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.6084/m9.figshare.11865603

Digital Object Identifier
Title: Supplementary Material for: Abnormal Baseline Lab Results Rarely Lead to Treatment Modification for Patients on Isotretinoin

Work title
Type: dataset

OpenAlex work type
Language: en

Primary language
Publication year: 2020

Year of publication
Publication date: 2020-01-01

Full publication date if available
Authors: Elizabeth Tkachenko, Preety Sharma, Arash Mostaghimi

List of authors in order
Landing page: https://doi.org/10.6084/m9.figshare.11865603

Publisher landing page
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://doi.org/10.6084/m9.figshare.11865603

Direct OA link when available
Concepts: Isotretinoin, Lead (geology), Baseline (sea), Medicine, Internal medicine, Dermatology, Biology, Acne, Fishery, Paleontology

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4394545614
doi	https://doi.org/10.6084/m9.figshare.11865603
ids.doi	https://doi.org/10.6084/m9.figshare.11865603
ids.openalex	https://openalex.org/W4394545614
fwci
type	dataset
title	Supplementary Material for: Abnormal Baseline Lab Results Rarely Lead to Treatment Modification for Patients on Isotretinoin
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T11553
topics[0].field.id	https://openalex.org/fields/27
topics[0].field.display_name	Medicine
topics[0].score	0.9975000023841858
topics[0].domain.id	https://openalex.org/domains/4
topics[0].domain.display_name	Health Sciences
topics[0].subfield.id	https://openalex.org/subfields/2708
topics[0].subfield.display_name	Dermatology
topics[0].display_name	Acne and Rosacea Treatments and Effects
topics[1].id	https://openalex.org/T11559
topics[1].field.id	https://openalex.org/fields/13
topics[1].field.display_name	Biochemistry, Genetics and Molecular Biology
topics[1].score	0.9818000197410583
topics[1].domain.id	https://openalex.org/domains/1
topics[1].domain.display_name	Life Sciences
topics[1].subfield.id	https://openalex.org/subfields/1312
topics[1].subfield.display_name	Molecular Biology
topics[1].display_name	Retinoids in leukemia and cellular processes
topics[2].id	https://openalex.org/T13467
topics[2].field.id	https://openalex.org/fields/27
topics[2].field.display_name	Medicine
topics[2].score	0.9483000040054321
topics[2].domain.id	https://openalex.org/domains/4
topics[2].domain.display_name	Health Sciences
topics[2].subfield.id	https://openalex.org/subfields/2731
topics[2].subfield.display_name	Ophthalmology
topics[2].display_name	Drug-Induced Ocular Toxicity
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C2776285725
concepts[0].level	3
concepts[0].score	0.6874775886535645
concepts[0].wikidata	https://www.wikidata.org/wiki/Q287029
concepts[0].display_name	Isotretinoin
concepts[1].id	https://openalex.org/C2777093003
concepts[1].level	2
concepts[1].score	0.6680701375007629
concepts[1].wikidata	https://www.wikidata.org/wiki/Q6508345
concepts[1].display_name	Lead (geology)
concepts[2].id	https://openalex.org/C12725497
concepts[2].level	2
concepts[2].score	0.6072890758514404
concepts[2].wikidata	https://www.wikidata.org/wiki/Q810247
concepts[2].display_name	Baseline (sea)
concepts[3].id	https://openalex.org/C71924100
concepts[3].level	0
concepts[3].score	0.4552059471607208
concepts[3].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[3].display_name	Medicine
concepts[4].id	https://openalex.org/C126322002
concepts[4].level	1
concepts[4].score	0.35363835096359253
concepts[4].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[4].display_name	Internal medicine
concepts[5].id	https://openalex.org/C16005928
concepts[5].level	1
concepts[5].score	0.16741052269935608
concepts[5].wikidata	https://www.wikidata.org/wiki/Q171171
concepts[5].display_name	Dermatology
concepts[6].id	https://openalex.org/C86803240
concepts[6].level	0
concepts[6].score	0.14426276087760925
concepts[6].wikidata	https://www.wikidata.org/wiki/Q420
concepts[6].display_name	Biology
concepts[7].id	https://openalex.org/C2777673923
concepts[7].level	2
concepts[7].score	0.0
concepts[7].wikidata	https://www.wikidata.org/wiki/Q79928
concepts[7].display_name	Acne
concepts[8].id	https://openalex.org/C505870484
concepts[8].level	1
concepts[8].score	0.0
concepts[8].wikidata	https://www.wikidata.org/wiki/Q180538
concepts[8].display_name	Fishery
concepts[9].id	https://openalex.org/C151730666
concepts[9].level	1
concepts[9].score	0.0
concepts[9].wikidata	https://www.wikidata.org/wiki/Q7205
concepts[9].display_name	Paleontology
keywords[0].id	https://openalex.org/keywords/isotretinoin
keywords[0].score	0.6874775886535645
keywords[0].display_name	Isotretinoin
keywords[1].id	https://openalex.org/keywords/lead
keywords[1].score	0.6680701375007629
keywords[1].display_name	Lead (geology)
keywords[2].id	https://openalex.org/keywords/baseline
keywords[2].score	0.6072890758514404
keywords[2].display_name	Baseline (sea)
keywords[3].id	https://openalex.org/keywords/medicine
keywords[3].score	0.4552059471607208
keywords[3].display_name	Medicine
keywords[4].id	https://openalex.org/keywords/internal-medicine
keywords[4].score	0.35363835096359253
keywords[4].display_name	Internal medicine
keywords[5].id	https://openalex.org/keywords/dermatology
keywords[5].score	0.16741052269935608
keywords[5].display_name	Dermatology
keywords[6].id	https://openalex.org/keywords/biology
keywords[6].score	0.14426276087760925
keywords[6].display_name	Biology
language	en
locations[0].id	doi:10.6084/m9.figshare.11865603
locations[0].is_oa	True
locations[0].source
locations[0].license	cc-by
locations[0].pdf_url
locations[0].version
locations[0].raw_type	dataset
locations[0].license_id	https://openalex.org/licenses/cc-by
locations[0].is_accepted	False
locations[0].is_published
locations[0].raw_source_name
locations[0].landing_page_url	https://doi.org/10.6084/m9.figshare.11865603
indexed_in	datacite
authorships[0].author.id	https://openalex.org/A5016027668
authorships[0].author.orcid	https://orcid.org/0000-0003-3629-8315
authorships[0].author.display_name	Elizabeth Tkachenko
authorships[0].author_position	first
authorships[0].raw_author_name	E. Tkachenko
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5103040850
authorships[1].author.orcid	https://orcid.org/0009-0005-9918-8449
authorships[1].author.display_name	Preety Sharma
authorships[1].author_position	middle
authorships[1].raw_author_name	P. Sharma
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5083722360
authorships[2].author.orcid	https://orcid.org/0000-0002-6084-5617
authorships[2].author.display_name	Arash Mostaghimi
authorships[2].author_position	last
authorships[2].raw_author_name	A. Mostaghimi
authorships[2].is_corresponding	False
has_content.pdf	False
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://doi.org/10.6084/m9.figshare.11865603
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Supplementary Material for: Abnormal Baseline Lab Results Rarely Lead to Treatment Modification for Patients on Isotretinoin
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T06:51:31.235846
primary_topic.id	https://openalex.org/T11553
primary_topic.field.id	https://openalex.org/fields/27
primary_topic.field.display_name	Medicine
primary_topic.score	0.9975000023841858
primary_topic.domain.id	https://openalex.org/domains/4
primary_topic.domain.display_name	Health Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2708
primary_topic.subfield.display_name	Dermatology
primary_topic.display_name	Acne and Rosacea Treatments and Effects
related_works	https://openalex.org/W2748952813, https://openalex.org/W3031052312, https://openalex.org/W4389568370, https://openalex.org/W3032375762, https://openalex.org/W1995515455, https://openalex.org/W2080531066, https://openalex.org/W3108674512, https://openalex.org/W1506200166, https://openalex.org/W1489783725, https://openalex.org/W2148612803
cited_by_count	0
locations_count	1
best_oa_location.id	doi:10.6084/m9.figshare.11865603
best_oa_location.is_oa	True
best_oa_location.source
best_oa_location.license	cc-by
best_oa_location.pdf_url
best_oa_location.version
best_oa_location.raw_type	dataset
best_oa_location.license_id	https://openalex.org/licenses/cc-by
best_oa_location.is_accepted	False
best_oa_location.is_published	False
best_oa_location.raw_source_name
best_oa_location.landing_page_url	https://doi.org/10.6084/m9.figshare.11865603
primary_location.id	doi:10.6084/m9.figshare.11865603
primary_location.is_oa	True
primary_location.source
primary_location.license	cc-by
primary_location.pdf_url
primary_location.version
primary_location.raw_type	dataset
primary_location.license_id	https://openalex.org/licenses/cc-by
primary_location.is_accepted	False
primary_location.is_published	False
primary_location.raw_source_name
primary_location.landing_page_url	https://doi.org/10.6084/m9.figshare.11865603
publication_date	2020-01-01
publication_year	2020
referenced_works_count	0
abstract_inverted_index.2	115
abstract_inverted_index.a	30, 72, 124, 166
abstract_inverted_index.10	117
abstract_inverted_index.We	28, 70
abstract_inverted_index.as	113, 173
abstract_inverted_index.at	43, 130, 141
abstract_inverted_index.be	165
abstract_inverted_index.by	136
abstract_inverted_index.in	145
abstract_inverted_index.is	15, 187
abstract_inverted_index.no	19
abstract_inverted_index.of	33, 59, 76, 116, 169, 180
abstract_inverted_index.or	157
abstract_inverted_index.to	41, 51, 90, 123, 160, 185
abstract_inverted_index.ALT	137
abstract_inverted_index.and	3, 18, 45, 47, 57, 82, 104
abstract_inverted_index.did	108
abstract_inverted_index.due	89, 122
abstract_inverted_index.for	6, 22, 37, 63, 93
abstract_inverted_index.lab	13, 91, 97, 125, 182
abstract_inverted_index.low	73
abstract_inverted_index.may	164
abstract_inverted_index.not	109, 139
abstract_inverted_index.our	162, 174
abstract_inverted_index.the	53, 178
abstract_inverted_index.was	128, 134
abstract_inverted_index.2008	40
abstract_inverted_index.2016	42
abstract_inverted_index.acne	38, 64
abstract_inverted_index.data	183
abstract_inverted_index.from	39
abstract_inverted_index.only	114
abstract_inverted_index.rate	74
abstract_inverted_index.that	127, 143, 177
abstract_inverted_index.this	24
abstract_inverted_index.use,	159
abstract_inverted_index.were	121
abstract_inverted_index.with	10, 65, 95, 147
abstract_inverted_index.work	175
abstract_inverted_index.early	83
abstract_inverted_index.exist	21
abstract_inverted_index.liver	105, 148
abstract_inverted_index.prior	184
abstract_inverted_index.tests	107
abstract_inverted_index.total	101, 118
abstract_inverted_index.value	179
abstract_inverted_index.(3.6%)	81
abstract_inverted_index.(7.2%)	75
abstract_inverted_index.course	5
abstract_inverted_index.driven	135
abstract_inverted_index.during	86, 171
abstract_inverted_index.group.	26
abstract_inverted_index.inform	161
abstract_inverted_index.result	126
abstract_inverted_index.review	32
abstract_inverted_index.(3.6%),	85
abstract_inverted_index.Brigham	44
abstract_inverted_index.General	49
abstract_inverted_index.alcohol	158
abstract_inverted_index.disease	156
abstract_inverted_index.hepatic	155
abstract_inverted_index.patient	25
abstract_inverted_index.predict	110
abstract_inverted_index.present	140
abstract_inverted_index.results	14
abstract_inverted_index.therapy	88
abstract_inverted_index.Abnormal	99
abstract_inverted_index.abnormal	11, 129
abstract_inverted_index.baseline	12, 66, 96, 100, 142, 181
abstract_inverted_index.changes,	112
abstract_inverted_index.clinical	4, 55
abstract_inverted_index.function	106
abstract_inverted_index.occurred	144
abstract_inverted_index.patients	7, 34, 60, 94, 146
abstract_inverted_index.relevant	152
abstract_inverted_index.superior	167
abstract_inverted_index.unclear.	188
abstract_inverted_index.unknown,	17
abstract_inverted_index.Hospitals	50
abstract_inverted_index.Treatment	1, 132
abstract_inverted_index.Women’s	46
abstract_inverted_index.baseline.	131
abstract_inverted_index.currently	16
abstract_inverted_index.elevation	138
abstract_inverted_index.including	79, 154
abstract_inverted_index.performed	29
abstract_inverted_index.predictor	168
abstract_inverted_index.treatment	77, 119
abstract_inverted_index.identified	71
abstract_inverted_index.initiating	8, 61
abstract_inverted_index.laboratory	67
abstract_inverted_index.management	58, 111
abstract_inverted_index.monitoring	23, 163
abstract_inverted_index.prescribed	35
abstract_inverted_index.treatment,	172
abstract_inverted_index.Emphasizing	151
abstract_inverted_index.investigate	52
abstract_inverted_index.termination	84
abstract_inverted_index.cholesterol,	102
abstract_inverted_index.demonstrates	176
abstract_inverted_index.interruption	80
abstract_inverted_index.isotretinoin	9, 36, 62, 87, 186
abstract_inverted_index.modification	2, 133
abstract_inverted_index.Massachusetts	48
abstract_inverted_index.abnormalities	92, 170
abstract_inverted_index.implications,	56
abstract_inverted_index.modification,	78
abstract_inverted_index.modifications	120
abstract_inverted_index.retrospective	31
abstract_inverted_index.triglyceride,	103
abstract_inverted_index.abnormalities.	68, 98
abstract_inverted_index.comorbidities,	153
abstract_inverted_index.comorbidities.	149
abstract_inverted_index.recommendations	20
abstract_inverted_index.characteristics,	54
abstract_inverted_index.<b><i>Methods:</i></b>	27
abstract_inverted_index.<b><i>Results:</i></b>	69
abstract_inverted_index.<b><i>Background:</i></b>	0
abstract_inverted_index.<b><i>Conclusion:</i></b>	150
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	3
citation_normalized_percentile